Vaccine News and Research

Latest Vaccine News and Research

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Scientists may have found a clue to why people living with HIV have double the likelihood of developing heart disease.

30 Aug 2017

$Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL$

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.

30 Aug 2017

Study finds low HPV vaccination rates among childhood cancer survivors

The rate of human papilloma virus (HPV) vaccination in the United States is increasing, but remains lower than ideal. A new study suggests that survivors of childhood cancer receive the HPV vaccine at an even lower rate than their peers without cancer ̶ 24% versus 40%. Nearly three quarters of study participants reported that their healthcare provider did not proactively recommend vaccination.

29 Aug 2017

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Vaccines and cancer immunotherapies do essentially the same thing: They boost a person's immune system, better enabling it to fight an offender, be it microbe or malignancy.

29 Aug 2017

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.

28 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

Studies reveal strategies for using shingles vaccine in arthritis patients

New research indicates that the live varicella-zoster vaccine--which is given to protect against shingles--elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib.

28 Aug 2017

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

26 Aug 2017

ESCMID conference brings together renowned experts to address most pressing questions on vaccines

Registration is open for the 4th ESCMID Conference on Vaccines. New and old diseases in children and adults: unmet needs in Dubrovnik, Croatia, Friday 8 September to Sunday 10 September 2017. Registration for bona fide journalists is free.

26 Aug 2017

Yale experts uncover genes associated with immune response to flu vaccination

Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.

26 Aug 2017

New study highlights role played by demographics in the spread of measles

Even if measles infection incidence has decreased by at least 90% all over the world since the introduction of the vaccine, measles is still one of the major causes of death in children among vaccine-preventable diseases.

26 Aug 2017

Uptake of HPV vaccination is worryingly low among childhood cancer survivors

A US national survey reports that even children who have had cancer previously, and are therefore at increased risk of developing further cancers, are not receiving vaccination against human papillomavirus (HPV).

25 Aug 2017

Survey finds lag in HPV vaccination rates for childhood cancer survivors

Despite being at an increased risk for cancers associated with the human papillomavirus, the first comprehensive national survey found that HPV vaccination rates for childhood cancer survivors lag well behind the national average and that health care providers often fail to recommend the vaccine.

24 Aug 2017

Influenza vaccination rates in children may decrease without option of nasal spray

Influenza vaccination rates in children may have decreased for the 2016-17 influenza season because of a recommendation by the Centers for Disease Control and Prevention that the nasal spray version of the vaccine not be used, according to Penn State College of Medicine researchers.

24 Aug 2017

UA Valley Fever Center For Excellence awarded NIH grant to accelerate vaccine development

The Valley Fever Center for Excellence at the University of Arizona College of Medicine - Tucson has been awarded a four-year, $4.8 million grant for research to speed development of a vaccine to combat Valley fever, the sometimes deadly respiratory illness caused by Coccidioides spores found in soils of the U.S. Southwest.

24 Aug 2017

USC scientist finds new approach to prevent HIV infection

Medical treatment that targets human proteins rather than ever-mutating viruses may one day help HIV-positive people whose bodies have built a resistance to "cocktails" currently used to keep them healthy, according to a Keck School of Medicine of USC researcher.

23 Aug 2017

Vaccine News and Research

Latest Vaccine News and Research

Experimental drug isolated from tick saliva may hold promise for reducing HIV-linked heart disease risk

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Study finds low HPV vaccination rates among childhood cancer survivors

Immune booster could improve effectiveness of vaccines and cancer immunotherapy

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Studies reveal strategies for using shingles vaccine in arthritis patients

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

ESCMID conference brings together renowned experts to address most pressing questions on vaccines

Yale experts uncover genes associated with immune response to flu vaccination

New study highlights role played by demographics in the spread of measles

Uptake of HPV vaccination is worryingly low among childhood cancer survivors

Survey finds lag in HPV vaccination rates for childhood cancer survivors

Influenza vaccination rates in children may decrease without option of nasal spray

UA Valley Fever Center For Excellence awarded NIH grant to accelerate vaccine development

USC scientist finds new approach to prevent HIV infection

New vaccine could offer protection against opioid combinations

Stable vaccines using microscopic crystals from cypovirus

Combination treatment effectively vaccinates mice against cancer

Children need to be up-to-date on immunizations before heading back-to-school

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in